APA (7th ed.) Citation

Schnitzbauer, A., Filmann, N., Adam, R., Bachellier, P., Bechstein, W. O., Becker, T., . . . Geissler, E. K. (2020). mTOR inhibition is most beneficial after liver transplantation for hepatocellular carcinoma in patients with active tumors. Annals of surgery, 272(5), . https://doi.org/10.1097/SLA.0000000000004280

Chicago Style (17th ed.) Citation

Schnitzbauer, Andreas, et al. "MTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients with Active Tumors." Annals of Surgery 272, no. 5 (2020). https://doi.org/10.1097/SLA.0000000000004280.

MLA (9th ed.) Citation

Schnitzbauer, Andreas, et al. "MTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients with Active Tumors." Annals of Surgery, vol. 272, no. 5, 2020, https://doi.org/10.1097/SLA.0000000000004280.